The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
4
- 1
Stoddart, Karen Lesley
Born in August 1957Individual (1 offspring)Officer
2024-03-01 ~ nowOF - Director → CIF 0 - 2
Mercer, Carolyn Victoria, Dr
Born in April 1980Individual (1 offspring)Officer 2024-09-24 ~ nowOF - Director → CIF 0 - 3
Cohen, Robin David
Born in November 1972Individual (1 offspring)Officer 2023-02-16 ~ nowOF - Director → CIF 0 - 4
Mr Anthony Taylor Rowlands
Born in June 1956Individual (5 offsprings)Person with significant control 2017-08-09 ~ nowPE - Ownership of shares – 75% or more → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0
Ceased
6
- 1
Schmidt, Meinhard Folkert
Chairman born in November 1960Individual (2 offsprings)Officer 2017-09-06 ~ 2018-04-11OF - Director → CIF 0 - 2
Eagling-vose, Elizabeth Sarah
Coo/Cfo born in September 1968IndividualOfficer 2022-04-01 ~ 2023-03-31OF - Director → CIF 0 - 3
Lloyd, Carol May
IndividualOfficer 2021-09-27 ~ 2025-04-17OF - Secretary → CIF 0 - 4
Bush, Andrew James
Director born in February 1962Individual (1 offspring)Officer 2017-08-09 ~ 2021-12-15OF - Director → CIF 0 - 5
Hipkiss, David John
Chief Executive born in September 1970Individual (4 offsprings)Officer 2017-09-06 ~ 2022-07-25OF - Director → CIF 0 - 6
Bonnet, Ludovic Gregoire, Dr
Vp Product Development born in March 1976IndividualOfficer 2018-11-12 ~ 2021-03-31OF - Director → CIF 0
Company in focus
AVAXZIPEN LIMITED
Previous name
ENESI PHARMA LIMITED - 2023-01-04
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Comprehensive Income/Expense
8,706,642 GBP2023-01-01 ~ 2023-12-31
9,887,520 GBP2022-01-01 ~ 2022-12-31
Equity
Called up share capital
210 GBP2023-12-31
315 GBP2022-12-31
102 GBP2022-01-01
Retained earnings (accumulated losses)
46,982,476 GBP2023-12-31
71,607,905 GBP2022-12-31
Equity
0 GBP2023-12-31
57,413,434 GBP2022-12-31
-14,194,054 GBP2022-01-01
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Cash and Cash Equivalents
265,535 GBP2023-12-31
469,932 GBP2022-12-31
Current Assets
1,279,369 GBP2023-12-31
1,749,737 GBP2022-12-31
Total assets
3,546,810 GBP2023-12-31
4,011,245 GBP2022-12-31
Total Borrowings
Non-current
25,862,520 GBP2023-12-31
50,807 GBP2022-12-31
Current
92,952 GBP2023-12-31
22,201,281 GBP2022-12-31
Total liabilities
27,037,943 GBP2023-12-31
23,149,056 GBP2022-12-31
Net Assets/Liabilities
-23,491,133 GBP2023-12-31
-19,137,811 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
-4,353,321 GBP2023-01-01 ~ 2023-12-31
-4,943,760 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-4,353,321 GBP2023-01-01 ~ 2023-12-31
-4,943,760 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-4,353,321 GBP2023-01-01 ~ 2023-12-31
-4,943,760 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
3 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
3 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
3 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
3 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Depreciation Expense
383,018 GBP2023-01-01 ~ 2023-12-31
392,115 GBP2022-01-01 ~ 2022-12-31
Audit Fees/Expenses
18,270 GBP2023-01-01 ~ 2023-12-31
17,400 GBP2022-01-01 ~ 2022-12-31
Wages/Salaries
1,740,035 GBP2023-01-01 ~ 2023-12-31
1,821,276 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
2,009,266 GBP2023-01-01 ~ 2023-12-31
2,097,992 GBP2022-01-01 ~ 2022-12-31
Current Tax for the Period
-661,429 GBP2023-01-01 ~ 2023-12-31
-1,090,298 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
-1,146,471 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,266,328 GBP2023-12-31
1,258,616 GBP2022-12-31
1,174,310 GBP2022-01-01
Furniture and fittings
616,581 GBP2023-12-31
616,581 GBP2022-12-31
599,316 GBP2022-01-01
Office equipment
61,075 GBP2023-12-31
61,075 GBP2022-12-31
51,211 GBP2022-01-01
Property, Plant & Equipment - Gross Cost
4,258,037 GBP2023-12-31
4,057,175 GBP2022-12-31
3,396,549 GBP2022-01-01
Property, Plant & Equipment - Other Disposals
-192,654 GBP2023-01-01 ~ 2023-12-31
-2,161 GBP2022-01-01 ~ 2022-12-31
Plant and equipment
-192,654 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
994,448 GBP2023-12-31
1,015,373 GBP2022-12-31
832,358 GBP2022-01-01
Furniture and fittings
541,021 GBP2023-12-31
413,117 GBP2022-12-31
291,593 GBP2022-01-01
Office equipment
54,032 GBP2023-12-31
46,301 GBP2022-12-31
40,879 GBP2022-01-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,990,596 GBP2023-12-31
1,795,667 GBP2022-12-31
1,405,487 GBP2022-01-01
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
167,164 GBP2023-01-01 ~ 2023-12-31
183,015 GBP2022-01-01 ~ 2022-12-31
Furniture and fittings
127,904 GBP2023-01-01 ~ 2023-12-31
121,524 GBP2022-01-01 ~ 2022-12-31
Office equipment
7,731 GBP2023-01-01 ~ 2023-12-31
7,357 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
383,018 GBP2023-01-01 ~ 2023-12-31
392,115 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-188,089 GBP2023-01-01 ~ 2023-12-31
-1,935 GBP2022-01-01 ~ 2022-12-31
Plant and equipment
-188,089 GBP2023-01-01 ~ 2023-12-31
Prepayments/Accrued Income
256,692 GBP2023-12-31
129,900 GBP2022-12-31
Amount of corporation tax that is recoverable
735,757 GBP2023-12-31
1,090,401 GBP2022-12-31
Trade Creditors/Trade Payables
Current
187,327 GBP2023-12-31
288,681 GBP2022-12-31
Accrued Liabilities
Current
475,120 GBP2023-12-31
519,805 GBP2022-12-31
Taxation/Social Security Payable
Current
42,593 GBP2023-12-31
57,868 GBP2022-12-31
Other Remaining Borrowings
Non-current
236,065 GBP2023-12-31
50,807 GBP2022-12-31
Current
92,952 GBP2023-12-31
96,090 GBP2022-12-31
Total Borrowings
25,955,472 GBP2023-12-31
22,252,088 GBP2022-12-31
Cash at bank and in hand
265,535 GBP2023-12-31
469,932 GBP2022-12-31
AVAXZIPEN LIMITED
InfoENESI PHARMA LIMITED - 2023-01-04Registered number 10908112
120a&b Olympic Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SAPRIVATE LIMITED COMPANY incorporated on 2017-08-09 (8 years 5 months). The company status is Active.The last date of confirmation statement was made at 2025-08-07CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.